RS
Raghbir Singh
About Raghbir Singh
Data last updated:
Raghbir Singh is a Director at Molsmed Drugs Private Limited (since 2022). The companies operate in Chemicals. Molsmed Drugs Private Limited reported revenue of ₹40.9 Lakh (FY 2025). Earlier, Raghbir Singh was a Director at Deksun Healthcare Private Limited (2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 Mar 2022 | 2022 | ₹40.9 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 14 Jan 2022 | 2022 | ₹11,181 (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Raghbir Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ranbir | 09537805 | Molsmed Drugs Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Raghbir Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Raghbir Singh
Raghbir Singh currently holds 1 directorship: Molsmed Drugs Private Limited (Director, since 16 Mar 2022, revenue ₹40.9 Lakh (FY 2025)).
Raghbir Singh was first appointed on 14 Jan 2022 as Director at Deksun Healthcare Private Limited.
Raghbir Singh held 1 earlier board appointment: Deksun Healthcare Private Limited (Director, 14 Jan 2022 to 06 Jul 2022).
The current boards of Raghbir Singh's companies include Ranbir (Molsmed Drugs Private Limited).